AMH and polycystic ovary syndrome: Given the well-described association between AMH as a surrogate marker for PCOM in a meta-analysis, with a pooled sensitivity of 0.79 and specificity of 0.87, serum AMH assays have been adopted as an alternative to ultrasound for the diagnosis of PCOM in terms of the diagnostic criteria for PCOS [5,14].